China Finance Online Co Ltd, January 11 news, today Xintian Pharmaceutical opened at 24.4 yuan, as of 13:50, the stock rose 10% to 26.84 yuan, sealed the limit.
Yesterday (2022-01-10) the net inflow of the stock was 288 million yuan, the main net inflow was 253 million yuan, the net inflow of China alone was 24.5294 million yuan, and the net inflow of retail investors was 10.1597 million yuan. (to view the real-time capital flow, please click)
In the last month, Xintian Pharmaceutical Co., Ltd. has been on the list of dragons and tigers for a total of 0 times, indicating that Xintian Pharmaceutical stocks are not active. (for more enquiries on the Dragon and Tiger list, please click)
The company is mainly engaged in the research, development, production and sales of proprietary Chinese medicine products for urological diseases, gynaecology and other diseases with complex causes, so as to provide safe and effective products for patients.
As of September 30, 2021, Xintian Pharmaceutical had an operating income of 745.26 million yuan, and the net profit belonging to the shareholders of the parent company was 88.933462 million yuan, an increase of 45.6587 percent over the same period last year, or 0.7727 yuan per share. (for more stock performance enquiries, please click)
Risk hint: the diagnosis results of individual stocks are made by processing objective data through the operation model, which is for reference only and does not constitute absolute investment recommendations.